260 related articles for article (PubMed ID: 26141191)
1. The novel mu-opioid antagonist, GSK1521498, reduces ethanol consumption in C57BL/6J mice.
Ripley TL; Sanchez-Roige S; Bullmore ET; Mugnaini M; Maltby K; Miller SR; Wille DR; Nathan P; Stephens DN
Psychopharmacology (Berl); 2015 Sep; 232(18):3431-41. PubMed ID: 26141191
[TBL] [Abstract][Full Text] [Related]
2. The Novel μ-Opioid Receptor Antagonist GSK1521498 Decreases Both Alcohol Seeking and Drinking: Evidence from a New Preclinical Model of Alcohol Seeking.
Giuliano C; Goodlett CR; Economidou D; García-Pardo MP; Belin D; Robbins TW; Bullmore ET; Everitt BJ
Neuropsychopharmacology; 2015 Dec; 40(13):2981-92. PubMed ID: 26044906
[TBL] [Abstract][Full Text] [Related]
3. Dissociation of μ-opioid receptor and CRF-R1 antagonist effects on escalated ethanol consumption and mPFC serotonin in C57BL/6J mice.
Hwa LS; Shimamoto A; Kayyali T; Norman KJ; Valentino RJ; DeBold JF; Miczek KA
Addict Biol; 2016 Jan; 21(1):111-24. PubMed ID: 25262980
[TBL] [Abstract][Full Text] [Related]
4. Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype.
Ziauddeen H; Nestor LJ; Subramaniam N; Dodds C; Nathan PJ; Miller SR; Sarai BK; Maltby K; Fernando D; Warren L; Hosking LK; Waterworth D; Korzeniowska A; Win B; Richards DB; Vasist Johnson L; Fletcher PC; Bullmore ET
Neuropsychopharmacology; 2016 Oct; 41(11):2647-57. PubMed ID: 27109624
[TBL] [Abstract][Full Text] [Related]
5. The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviours.
Kelly E; Mundell SJ; Sava A; Roth AL; Felici A; Maltby K; Nathan PJ; Bullmore ET; Henderson G
Psychopharmacology (Berl); 2015 Jan; 232(1):305-14. PubMed ID: 24973897
[TBL] [Abstract][Full Text] [Related]
6. Ethanol consumption by Fawn-Hooded rats following abstinence: effect of naltrexone and changes in mu-opioid receptor density.
Cowen MS; Rezvani AH; Jarrott B; Lawrence AJ
Alcohol Clin Exp Res; 1999 Jun; 23(6):1008-14. PubMed ID: 10397284
[TBL] [Abstract][Full Text] [Related]
7. Morphine attenuates the expression of sensitization to ethanol, but opioid antagonists do not.
Abrahao KP; Quadros IM; Souza-Formigoni ML
Neuroscience; 2008 Oct; 156(4):857-64. PubMed ID: 18804151
[TBL] [Abstract][Full Text] [Related]
8. Gene transcription alterations associated with decrease of ethanol intake induced by naltrexone in the brain of Wistar rats.
Oliva JM; Manzanares J
Neuropsychopharmacology; 2007 Jun; 32(6):1358-69. PubMed ID: 17063152
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of opioid transmission at the μ-opioid receptor prevents both food seeking and binge-like eating.
Giuliano C; Robbins TW; Nathan PJ; Bullmore ET; Everitt BJ
Neuropsychopharmacology; 2012 Nov; 37(12):2643-52. PubMed ID: 22805601
[TBL] [Abstract][Full Text] [Related]
10. Acute effects of naltrexone and GBR 12909 on ethanol drinking-in-the-dark in C57BL/6J mice.
Kamdar NK; Miller SA; Syed YM; Bhayana R; Gupta T; Rhodes JS
Psychopharmacology (Berl); 2007 Jun; 192(2):207-17. PubMed ID: 17273875
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence.
Walker BM; Koob GF
Neuropsychopharmacology; 2008 Feb; 33(3):643-52. PubMed ID: 17473837
[TBL] [Abstract][Full Text] [Related]
12. Ethanol drinking-in-the-dark facilitates behavioral sensitization to ethanol in C57BL/6J, BALB/cByJ, but not in mu-opioid receptor deficient CXBK mice.
Tarragón E; Baliño P; Aragon CM; Pastor R
Pharmacol Biochem Behav; 2012 Mar; 101(1):14-23. PubMed ID: 22138236
[TBL] [Abstract][Full Text] [Related]
13. Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats.
Ciccocioppo R; Martin-Fardon R; Weiss F
Neuropsychopharmacology; 2002 Sep; 27(3):391-9. PubMed ID: 12225696
[TBL] [Abstract][Full Text] [Related]
14. Delta receptor antagonism, ethanol taste reactivity, and ethanol consumption in outbred male rats.
Higley AE; Kiefer SW
Alcohol; 2006 Nov; 40(3):143-50. PubMed ID: 17418693
[TBL] [Abstract][Full Text] [Related]
15. Regulation of ingestive behaviors in the rat by GSK1521498, a novel micro-opioid receptor-selective inverse agonist.
Ignar DM; Goetz AS; Noble KN; Carballo LH; Stroup AE; Fisher JC; Boucheron JA; Brainard TA; Larkin AL; Epperly AH; Shearer TW; Sorensen SD; Speake JD; Hommel JD
J Pharmacol Exp Ther; 2011 Oct; 339(1):24-34. PubMed ID: 21712426
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of cocaine and heroin seeking by μ-opioid receptor antagonism.
Giuliano C; Robbins TW; Wille DR; Bullmore ET; Everitt BJ
Psychopharmacology (Berl); 2013 May; 227(1):137-47. PubMed ID: 23299095
[TBL] [Abstract][Full Text] [Related]
17. Opioidergic modulation of ethanol self-administration in the ventral pallidum.
Kemppainen H; Raivio N; Suo-Yrjo V; Kiianmaa K
Alcohol Clin Exp Res; 2012 Feb; 36(2):286-93. PubMed ID: 21895714
[TBL] [Abstract][Full Text] [Related]
18. Naltrexone effects on ethanol drinking acquisition and on established ethanol consumption in C57BL/6J mice.
Phillips TJ; Wenger CD; Dorow JD
Alcohol Clin Exp Res; 1997 Jun; 21(4):691-702. PubMed ID: 9194926
[TBL] [Abstract][Full Text] [Related]
19. The effects of alcohol on the pharmacokinetics and pharmacodynamics of the selective mu-opioid receptor antagonist GSK1521498 in healthy subjects.
Ziauddeen H; Nathan PJ; Dodds C; Maltby K; Miller SR; Waterworth D; Song K; Warren L; Hosking L; Zucchetto M; Bush M; Johnson LV; Sarai B; Mogg K; Bradley BP; Richards DB; Fletcher PC; Bullmore ET
J Clin Pharmacol; 2013 Oct; 53(10):1078-90. PubMed ID: 23934621
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and beta-funaltrexamine on ethanol consumption in the rat.
Stromberg MF; Casale M; Volpicelli L; Volpicelli JR; O'Brien CP
Alcohol; 1998 May; 15(4):281-9. PubMed ID: 9590512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
